{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00774930","recordId":"NCT00774930","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00774930-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00774930.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00774930.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2008-10-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2008-10-16","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"69919f9457efc572895e69361ac99f862f4f8715e660203f421aae024b2e45b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2008-10-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2008-10-27","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1ec908882bc89efa3bb997e26e35a727d1eac79ff1a1af861f2f8ead7c42cf5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2009-03-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2009-03-20","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c337184e886fb2b3fe5e3f0bcb0a83b4b7afcfe53ead5f8beffe337e23f96744","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2009-06-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2009-06-25","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1804fde982e8ae154a7b13f70ab2aaa059cd462aaf2af3f9e23defd4be50d921","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2009-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2009-06-26","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"e7bda35965083e540e7c45eaa28ca2f3aeb3cb5a5c6c79bbe20faf3c76be8106","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-03-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-03-09","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"5359117babf1c99f0e79a829e9b6853ee95618f2ad6539e0bbfbfef4a334c563","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2010-04-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-04-29","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"41283b79a27a284573901b6cb1a1e5647c566698cb1d6cdc289625dec45e9b69","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2010-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-05-11","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"fc775f6ddff62ac311d5b2266d0de92e3e163f16b5751f52563137850eeb92e5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2010-07-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-07-27","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"d080bdc036186e006caacbc8bbd79e8a994e506a927b77bf5a77a27fefe48de5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2010-11-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-11-23","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"51e3d9d223a3bc5c1732d0ebc6268bd3dc422cbc367dc958b1526eed7cfbba94","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2011-02-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-02-28","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"128e2a0b675ac769c37687bc03a2498156a3361f14e803b596bd7534bc26f313","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2011-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-05-03","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"14e755de7eb326d787a6f6be327873b5a5f2129db47ee1d5ae2868984c53b23c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","Study Identification","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2011-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-06-08","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c4dc8611ff296d724e32d9d0afe0fcd3d22bc5d9ec7c5df0cf969f1075eec3ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Sponsor/Collaborators","Study Description","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2011-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-10-20","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"18b9af5efa0d866c5802f18aac7226810d49f575516451e4fe26cd026fd3e2c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2012-01-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-01-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c82012dea8e5e3e0c8e1bb81cb234740f222d4f076b8fc17da800a71f535d74c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2012-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-04-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"825cd7d749738c7543834398a3b4dee027f7306f380c05ea220c5d3b12efbd34","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2012-05-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-05-28","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"fe51f26550c29fb8ba50e478149f695f066ded69f4f642289c0e8bcf6b02a2b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2012-07-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-07-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"731f13c9b4b8fd68f16c24e9e923e62c37944c6bfaa02295776ef6c10b19f3f8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2012-10-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-10-02","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"576e0916df1390fc14419285e6e93920dd94b4409129f332af95db8a9a08b292","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2012-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-10-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c6d206386bcc85cc2d5b392eeaf4a8a422c64eff295a82c8d6533705c125f25d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2012-12-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-12-24","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"b5a761f95acf8e9bd3f74e62cf9eebc9cecec676c4fa1ddcfdddc9e46c7e5364","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2013-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2013-02-26","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"4ab559ba9535776dd5dae0c08aaf689da38d6daf54d444efa786e67af4476eca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2013-08-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2013-08-29","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1753122be3c62cffc0c474383894202e74114ff7ab45271fede71866185e83cd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Design","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2014-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-02-26","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1b5c29f07bc5ceadb10be0bcfbb8b241260efa4fa038e014923b0775794b7059","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2016-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2016-01-07","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"3b131cf387bbdc3935827c60af376f905de7c519145c9659518e6db36e9195c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Conditions","Eligibility","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Description","Study Identification","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2016-12-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2016-12-28","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"f3d7d7a59ab169f34ccd4835d8c0d3223e4e428423d5e24378784bda3e1150bf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Outcome Measures (Results)","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2019-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2019-01-10","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"8e5ca81f25300033dc9d558143f3dfebef55292e2dff5ecf35692d51d0c13944","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures (Results)","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2020-11-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2020-11-04","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"8de0fd1d6eac585e0b8fcfe6be0942b3e946f46f3d24783a338cc49ebfd336a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2022-09-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2022-09-15","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"971d7da3729f445a7b012c43337896eef8080d3c0c0ef7104d1efd8bc02e9d9f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=29&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"fcfe01829c78e70f5201ce4639b68e8df77453ec9740bf3fee64a90055db48ae"}}